Antiviral Therapy and the Development of Hepatocellular Carcinoma (HCC) in Chronic Hepatitis B (CHB) Patients with and without Cirrhosis in a US Population

被引：0
|
作者：
Lin, Derek [1 ]
Nguyen, Nghia H. [2 ]
Hoang, Joseph [3 ]
Vu, Vinh D. [3 ]
Trinh, Huy N. [4 ]
Li, Jiayi [5 ]
Zhang, Jian Q. [6 ]
Nguyen, Huy A. [4 ]
Khanh Nguyen [4 ]
Nguyen, Mindie H. [3 ]
机构：
[1] Stanford Univ Med Ctr, Palo Alto, CA USA
[2] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
[3] Stanford Univ Med Ctr, Div Gastroenterol & Hepatol, Palo Alto, CA USA
[4] San Jose Gastroenterol, San Jose, CA USA
[5] Palo Alto Med Fdn, Palo Alto, CA USA
[6] Chinese Hosp, San Francisco, CA USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1641
引用
收藏
页码：988A / 988A
页数：1
相关论文
共 50 条
  • [21] Risk of hepatocellular carcinoma (HCC) in hepatitis C patients without cirrhosis
    Madhoun, Mohammad
    Fazili, Javid
    Bader, Teddy
    Roberts, David
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S156 - S157
  • [22] Hepatocellular Carcinoma Incidence in a Cohort of 981 US Patients With Chronic Hepatitis B Without Cirrhosis and Patients With Cirrhosis of All Etiologies
    Do, Ailinh L.
    Wong, Carrie R.
    Nguyen, Vincent
    Garcia, Ruel T.
    Trinh, Huy N.
    Kin, Kevin
    Nguyen, Huy A.
    Nguyen, Khanh K.
    Levitt, Brian S.
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2010, 138 (05) : S776 - S776
  • [23] RISK FACTORS FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AFTER ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B PATIENTS
    Chen, Junjie
    Feng, Tienan
    Zhang, Xinxin
    HEPATOLOGY, 2023, 78 : S491 - S492
  • [24] RISK OF HEPATOCELLULAR CARCINOMA (HCC) IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH OR WITHOUT CIRRHOSIS TREATED WITH ORAL ANTIVIRALS: RESULTS OF THE NATIONWIDE HEPNET.GREECE COHORT STUDY
    Papatheodoridis, George V.
    Manolakopoulos, Spilios
    Touloumi, Giota
    Vourli, Georgia
    Raptopoulou-Gigi, Maria
    Vafiadis-Zouboulis, Irini
    Vasileiadis, Themistoklis
    Mimidis, Konstantinos
    Gogos, Charalambos
    Ketikoglou, Ioannis
    Manesis, Emanuel K.
    HEPATOLOGY, 2009, 50 (04) : 368A - 369A
  • [25] ASSOCIATION OF ASPIRIN WITH HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B WITH OR WITHOUT CIRRHOSIS
    Jang, Heejoon
    Lee, Yun Bin
    Moon, Hyemi
    Park, Minkyung
    Choi, Na Ryung
    Kim, Minseok Albert
    Nam, Joon Yeul
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Lee, Juneyoung
    Yoon, Jung-Hwan
    HEPATOLOGY, 2020, 72 : 115A - 115A
  • [26] Antiviral therapy in patients with chronic hepatitis B and cirrhosis
    Lai, CJ
    Terrault, NA
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (03) : 629 - +
  • [27] Can antiviral therapy of chronic hepatitis B prevent the development of hepatocellular carcinoma?
    Thursz, Mark
    Brown, Ashley
    GUT, 2011, 60 (08) : 1025 - 1026
  • [28] Reply to: "Hepatocellular carcinoma (HCC) in the absence of cirrhosis in patients with chronic hepatitis B virus infection"
    Chayanupatkul, Maneerat
    Kanwal, Fasiha
    JOURNAL OF HEPATOLOGY, 2017, 67 (04) : 886 - 887
  • [29] Lower Incidence of Hepatocellular Carcinoma (HCC) with Antiviral Therapy in Chronic Hepatitis B (CHB) Patients without Cirrhosis and Normal to Minimally Elevated Alanine Aminotransferase (ALT) Levels (< 2x upper limit of normal or ULN)
    Hoang, Joseph K.
    Nguyen, Nghia H.
    Yang, Hwai-I
    Lin, Derek
    Vu, Vinh D.
    Chaung, Kevin T.
    Nguyen, Vincent G.
    Le, An K.
    Trinh, Huy N.
    Li, Jiayi
    Zhang, Jian Q.
    Chen, Chien-Jen
    Nguyen, Mindie H.
    HEPATOLOGY, 2015, 62 : 972A - 972A
  • [30] Increase in Hepatocellular carcinoma (HCC) in Hepatitis C (HCV) patients without cirrhosis
    Allampati, Sanath K.
    Krupica, Troy
    Lopez, Rocio
    Samaan, Maggie H.
    Dasarathy, Srinivasan
    McCullough, Arthur J.
    HEPATOLOGY, 2017, 66 : 534A - 534A
12345